These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3456480)

  • 21. Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients.
    Gerra G; Leonardi C; Cortese E; Zaimovic A; Dell'agnello G; Manfredini M; Somaini L; Petracca F; Caretti V; Saracino MA; Raggi MA; Donnini C
    J Neural Transm (Vienna); 2007; 114(12):1637-47. PubMed ID: 17690947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mental stress on plasma homovanillic acid in healthy human subjects.
    Sumiyoshi T; Yotsutsuji T; Kurachi M; Itoh H; Kurokawa K; Saitoh O
    Neuropsychopharmacology; 1998 Jul; 19(1):70-3. PubMed ID: 9608578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in human urine homovanillic acid concentration after neuroleptic treatment is the same with or without debrisoquin administration.
    Contreras SA; Maas JW; Seleshi E; Bowden CL
    Arch Gen Psychiatry; 1987 Dec; 44(12):1109-10. PubMed ID: 3689099
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of ceruletide on plasma monoamine metabolites in the rabbit.
    Wakata N; Kawamura Y; Kobayashi M; Sumiyoshi S; Okada K; Kinoshita M
    J Neurol Sci; 1991 May; 103(1):97-100. PubMed ID: 1713954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex.
    Zhang ZJ; Peet M; Ramchand CN; Shah S; Reynolds GP
    J Psychiatr Res; 2001; 35(1):23-8. PubMed ID: 11287053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased catecholamine output in the hypertensive fawn-hooded rat.
    Magro AM; Rudofsky UH; Gilboa N; Seegal R
    Lab Anim Sci; 1986 Dec; 36(6):646-9. PubMed ID: 3821054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactions.
    Kahn RS; Davidson M; Kanof P; McQueeney RT; Singh RR; Davis KL
    Psychopharmacology (Berl); 1991; 103(1):95-8. PubMed ID: 2006246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma HVA in psychiatric patients: longitudinal studies.
    Javaid JI; Sharma RP; Janicak PG; Davis JM
    Psychopharmacol Bull; 1990; 26(3):361-5. PubMed ID: 2274637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.
    Bacopoulos NG; Hattox SE; Roth RH
    Eur J Pharmacol; 1979 Jun; 56(3):225-36. PubMed ID: 477719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of exogenous factors affecting plasma homovanillic acid concentration.
    Davidson M; Giordani AB; Mohs RC; Mykytyn VV; Platt S; Aryan ZS; Davis KL
    Psychiatry Res; 1987 Apr; 20(4):307-12. PubMed ID: 3602216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the central or peripheral origin of free and sulfated 3,4-dihydroxyphenylacetic acid in rat plasma.
    Boudet C; Peyrin L; Tavitian E; Claustre J; Favre R
    Eur J Pharmacol; 1984 Aug; 103(3-4):295-301. PubMed ID: 6149138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
    Lambert GW; Eisenhofer G; Cox HS; Horne M; Kalff V; Kelly M; Jennings GL; Esler MD
    Life Sci; 1991; 49(15):1061-72. PubMed ID: 1895870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The debrisoquin hydroxylation phenotype does not predict the metabolism of phenytoin.
    Steiner E; Alván G; Garle M; Maguire JH; Lind M; Nilson SO; Tomson T; McClanahan JS; Sjöqvist F
    Clin Pharmacol Ther; 1987 Sep; 42(3):326-33. PubMed ID: 3621788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients.
    Ferrari M; Termine C; Franciotta D; Castiglioni E; Pagani A; Lanzi G; Marino F; Lecchini S; Cosentino M; Balottin U
    J Psychiatr Res; 2008 Nov; 43(1):24-9. PubMed ID: 18329046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiologic heterogeneity of the psychoses: is there a dopamine psychosis?
    Garver DL; Steinberg JL; McDermott BE; Yao JK; Ramberg JE; Lewis S; Kingsbury SJ
    Neuropsychopharmacology; 1997 Mar; 16(3):191-201. PubMed ID: 9138435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cirrhosis and debrisoquin phenotype on the disposition and effects of pinacidil.
    Shaheen O; Patel J; Avant GR; Hamilton M; Wood AJ
    Clin Pharmacol Ther; 1986 Dec; 40(6):650-5. PubMed ID: 3780126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
    Zhang ZJ; Reynolds GP; Ramchand C; Peet M; Shah S
    Acta Pharmacol Sin; 2001 Jan; 22(1):76-80. PubMed ID: 11730567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between plasma homovanillic acid and outcome in patients with psychosis spectrum disorders.
    van de Kerkhof NW; Fekkes D; van der Heijden FM; Egger JI; Verhoeven WM
    Neuropsychobiology; 2015; 71(4):212-7. PubMed ID: 26279280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.